Last reviewed 2026-04-20 · How we verify

Omniscan

At a glance

Approved indications

• Magnetic resonance imaging

Common side effects

• Nausea
• Headache
• Dizziness
• Injection site reaction
• Vasodilation
• Anaphylactoid reactions
• Fever
• Hot flushes
• Rigors
• Fatigue
• Malaise
• Pain

Serious adverse events

• Nephrogenic Systemic Fibrosis
• Cardiac failure
• Myocardial infarction
• Arrhythmia
• Acute renal failure
• Acute pancreatitis
• Acute respiratory distress syndrome
• Pulmonary edema
• Deep thrombophlebitis
• Aggravated multiple sclerosis

Key clinical trials

• Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years (PHASE4)
• Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging (PHASE4)
• A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide (PHASE3)
• A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using Gadodiamide (PHASE3)
• Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer (NA)
• Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI) (PHASE4)
• Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
• A Study of Gadodiamide Injection in Myocardial Perfusion Magnetic Resonance Imaging (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.